{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:10:38Z","timestamp":1792649438549,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["NU62PS924778"],"award-info":[{"award-number":["NU62PS924778"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10461-025-04728-5","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T01:41:56Z","timestamp":1745804516000},"page":"2043-2053","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Rapid Diffusion of Awareness and Uptake of Doxy-PEP among Men who Have Sex with Men in San Francisco"],"prefix":"10.1007","volume":"29","author":[{"given":"Antonio A. M.","family":"Moscatelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma L.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bow","family":"Suprasert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moranda","family":"Tate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Amelia S. M.","family":"Veras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda","family":"Baguso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4148-5660","authenticated-orcid":false,"given":"Willi","family":"McFarland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"4728_CR1","unstructured":"World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections. 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240027077. Accessed December 14, 2024."},{"key":"4728_CR2","unstructured":"European Centre for Disease Prevention and Control. Surveillance Atlas of Infectious Diseases. 2023.https:\/\/www.ecdc.europa.eu\/en\/surveillance-atlas-infectious-diseases. Accessed December 14, 2024."},{"key":"4728_CR3","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted disease surveillance. 2021. https:\/\/www.cdc.gov\/sti-statistics\/media\/pdfs\/2024\/07\/2021-STD-Surveillance-Report-PDF_ARCHIVED-2-16-24.pdf. Accessed December 14, 2024."},{"key":"4728_CR4","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted disease surveillance. 2023. https:\/\/www.cdc.gov\/sti-statistics\/annual\/index.html. Accessed December 14, 2024."},{"key":"4728_CR5","unstructured":"San Francisco Department of Public Health. Sexually Transmitted Infection Annual Summary. 2021. https:\/\/www.sf.gov\/sites\/default\/files\/2024-07\/Annual%20Summary%202021.pdf. Accessed December 14, 2024."},{"key":"4728_CR6","unstructured":"San Francisco Department of Public Health. HIV Annual Report. 2023. https:\/\/www.sf.gov\/sites\/default\/files\/2024-09\/AnnualReport2023%20Yellow%2020240923%20Final%20w%20Covers_2.pdf. Accessed December 14, 2024."},{"issue":"No RR\u20132","key":"4728_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7302a1","volume":"73","author":"LH Bachmann","year":"2024","unstructured":"Bachmann LH, Barbee LA, Chan P, et al. CDC clinical guidelines on the use of Doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention, united States, 2024. MMWR Recomm Rep. 2024;73(No RR\u20132):1\u20138. https:\/\/doi.org\/10.15585\/mmwr.rr7302a1.","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"4728_CR8","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S1473-3099(17)30725-9","volume":"18","author":"JM Molina","year":"2018","unstructured":"Molina JM, Charreau I, Chidiac C, et al. Post-exposure prophylaxis with Doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomized substudy of the ANRS IPERGAY trial. Lancet Infect Dis. 2018;18(3):308\u201317.","journal-title":"Lancet Infect Dis"},{"key":"4728_CR9","unstructured":"Molina JM, Bercot B, Assoumou L et al. ANRS 174 DOXYVAC: an open-label randomized trial to prevent STIs in MSM on PrEP. The Conference on Retroviruses and Opportunistic Infections. Abstract 119. February, 19\u201322, 2023; Seattle, Washington."},{"issue":"14","key":"4728_CR10","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa2211934","volume":"388","author":"AF Luetkemeyer","year":"2023","unstructured":"Luetkemeyer AF, Donnell D, Dombrowski JC, et al. Postexposure Doxycycline to prevent bacterial sexually transmitted infections. N Engl J Med. 2023;388(14):1296\u2013306.","journal-title":"N Engl J Med"},{"key":"4728_CR11","unstructured":"San Francisco Department of Public Health. Health Update: Doxycycline Post-Exposure Prophylaxis Reduces Incidence of Sexually Transmitted Infections, October 20. 2022. https:\/\/www.sf.gov\/sites\/default\/files\/2024-04\/Health-Update-Doxycycline-Post-Exposure-Prophylaxis-Reduces-Incidence-of-Sexually-Transmitted-Infections-SFDPH-FINAL-10.20.2022.cleaned.pdf. Accessed December 14, 2024."},{"key":"4728_CR12","unstructured":"National Coalition of STD Directors. Doxy and STI PEP Sample Policies. https:\/\/www.ncsddc.org\/resource\/doxy-and-sti-pep-sample-policies\/. Accessed December 14, 2024."},{"key":"4728_CR13","unstructured":"San Francisco Department of Public Health. Health Update: Updated Recommendations for Prescribing Doxycycline Post-Exposure Prophylaxis (Doxy- PEP), September 12. 2024. https:\/\/www.sf.gov\/sites\/default\/files\/2024-09\/Update-Updated-Recommendations-Prescribing-Doxy-PEP-SFDPH-FINAL-9.12.24.pdf. Accessed December 14, 2024."},{"key":"4728_CR14","unstructured":"Cohen SE. Translating evidence into action for public health: the doxy-PEP story. https:\/\/plus.iasociety.org\/sites\/default\/files\/2024-05\/Stephanie-Cohen-presentation-slides.pdf. Accessed December 14, 2024."},{"key":"4728_CR15","unstructured":"Centers for Disease Control and Prevention. National HIV Behavioral Surveillance System Round 7. Model Surveillance Protocol. https:\/\/www.cdc.gov\/hiv-data\/media\/pdfs\/nhbs\/NHBS_Model_Protocol_Round7_2023.pdf. Accessed December 14, 2024."},{"issue":"11","key":"4728_CR16","doi-asserted-by":"publisher","first-page":"e39053","DOI":"10.2196\/39053","volume":"8","author":"D Kanny","year":"2022","unstructured":"Kanny D, Broz D, Finlayson T, Lee K, Sionean C, Wejnert C, NHBS Study Group. A key comprehensive system for biobehavioral surveillance of populations disproportionately affected by HIV (National HIV behavioral surveillance): Cross-sectional Survey Study. JMIR Public Health Surveill. 2022;8(11):e39053. https:\/\/doi.org\/10.2196\/39053.","journal-title":"JMIR Public Health Surveill"},{"key":"4728_CR17","volume-title":"Release 18","author":"StataCorp","year":"2023","unstructured":"StataCorp. Stata statistical software. Release 18. College Station, TX: StataCorp LLC; 2023."},{"key":"4728_CR18","doi-asserted-by":"publisher","unstructured":"Wagner L, Boesecke C, Baumgarten A, et al. Is Doxycycline post-exposure prophylaxis being utilised in Germany? Insights from an online survey among German men who have sex with men. Infection. 2024;23. https:\/\/doi.org\/10.1007\/s15010-024-02321-x.","DOI":"10.1007\/s15010-024-02321-x"},{"key":"4728_CR19","doi-asserted-by":"publisher","unstructured":"Sergio BV, Ruben M, Luis V. A practice already in use: a snapshot survey on the use of doxycycline as a preventive strategy (Doxy-PEP and Doxy-PrEP) in the GBMSM population in Spain. Infection. 2024 https:\/\/doi.org\/10.1007\/s15010-024-02320-y. https:\/\/pubmed.ncbi.nlm.nih.gov\/39060908\/","DOI":"10.1007\/s15010-024-02320-y"},{"key":"4728_CR20","unstructured":"San Francisco of Public Health. HIV Annual Report. 2020. https:\/\/www.sf.gov\/sites\/default\/files\/2024-04\/HIV_Epi_Annual%20Report_2020.pdf. Accessed December 24, 2024."},{"key":"4728_CR21","unstructured":"US Food and Drug Agency. Truvada for PrEP Fact Sheet: Ensuring Safe and Proper Use. https:\/\/www.fda.gov\/files\/drugs\/published\/Truvada-for-PrEP-Fact-Sheet--Ensuring-Safe-and-Proper-Use.pdf. Accessed December 14, 2024."},{"key":"4728_CR22","doi-asserted-by":"publisher","unstructured":"Holt M, Bavinton BR, Calabrese SK, et al. Acceptability of Doxycycline prophylaxis, prior antibiotic use, and knowledge of antimicrobial resistance among Australian gay and bisexual men and non-binary people. Sex Transm Dis. 2024; 24. https:\/\/doi.org\/10.1097\/OLQ.0000000000002079.","DOI":"10.1097\/OLQ.0000000000002079"},{"key":"4728_CR23","doi-asserted-by":"publisher","unstructured":"Brookins T, Reagan D, Tate M et al. Disparities in HIV testing and PrEP awareness for black women who inject drugs in San Francisco, California. AIDS behav 2024 Apr 20. https:\/\/doi.org\/10.1007\/s10461-024-04338-7","DOI":"10.1007\/s10461-024-04338-7"},{"key":"4728_CR24","unstructured":"Chicago AIDS, Foundation. Your questions about Doxy-PEP, answered by India Willis, MPH, MSN, FNP-BC. https:\/\/www.aidschicago.org\/your-questions-about-doxy-pep-answered\/. Accessed December 14, 2024."},{"key":"4728_CR25","unstructured":"San Francisco AIDS, Foundation. About Doxy PEP for prevention of STIs. https:\/\/www.sfaf.org\/collections\/beta\/about-doxy-pep-for-prevention-of-stis\/. Accessed December 14, 2024."}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04728-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-025-04728-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04728-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T02:52:25Z","timestamp":1751856745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-025-04728-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["4728"],"URL":"https:\/\/doi.org\/10.1007\/s10461-025-04728-5","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"5 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare they have no financial or non-financial interests that are directly or indirectly related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors certify that the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Participation was anonymous. All participants provided verbal informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}